Vaccines for immunization programs play a pivotal role in the prevention and control of infectious diseases in China. Since the implementation of the Expanded Program on Immunization in 2007, a total of 15 vaccines have been used in the national immunization program, which can prevent 15 kinds of diseases. The development of vaccines in China's immunization program in the past decade is analyzed in terms of variety, quantity, production enterprise, quality standard, and supervision system. The results show that the average dose of vaccines for China's immunization planning is about 570 million doses per year from 2011 to 2020. The overall development of the vaccine industry for immunization planning is stable, and there are between one to five manufacturers for each type of vaccine mainly relying on domestic production. Vaccine quality standards have been continuously improved and are basically consistent with international standards. The vaccine supervision system has been continuously completed and covered the entire process of research and development, production and distribution.
免疫规划用疫苗在中国传染病预防控制方面起到举足轻重的作用。我国自2007年实施扩大免疫规划以来，免疫规划用疫苗共计15种，可以预防15种疾病。本文从品种、数量、生产企业、质量标准、监管体系5个方面详细分析了近十年中国免疫规划疫苗的发展状况。研究结果显示，2011—2020年中国免疫规划用疫苗平均剂量约为5.7亿剂次/年；免疫规划用疫苗行业整体发展平稳，每类疫苗生产企业在1~5家之间且主要依靠国内生产；疫苗质量标准不断提高且与国际标准基本一致；疫苗监管体系不断完善，覆盖了研发、生产、流通全流程监管。.